Literature DB >> 20003906

Prolonged shedding of influenza A(H1N1)v virus: two case reports from France 2009.

H Fleury1, S Burrel, C Balick Weber, R Hadrien, P Blanco, C Cazanave, M Dupon.   

Abstract

We observed a prolonged shedding of virus 14 and 28 days after symptom onset in two patients with pandemic H1N1 influenza, who did not have immunodepression and were treated with neuraminidase inhibitor. This prolonged shedding was not associated with the emergence of resistance mutation H275Y in the viral neuraminidase gene.

Entities:  

Mesh：

Year:  2009        PMID： 20003906

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  11 in total

1.  Influenza in obese travellers: increased risk and complications, decreased vaccine effectiveness.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  J Travel Med       Date:  2019-05-10       Impact factor: 8.490

2.  Persistent oseltamivir-resistant pandemic influenza A/H1N1 infection in an adult with cystic fibrosis.

Authors:  William George Flight; Rowland Bright-Thomas; Kenneth Mutton; Kevin Webb; Andrew Jones
Journal:  BMJ Case Rep       Date:  2011-04-26

3.  H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis.

Authors:  Thiago Moreno L Souza; Jorge I F Salluh; Fernando A Bozza; Milene Mesquita; Márcio Soares; Fernando C Motta; Melissa Tassano Pitrowsky; Maria de Lourdes Oliveira; Vasiliy P Mishin; Larissa V Gubareva; Anne Whitney; Sandra Amaral Rocco; Vânia Maria C Gonçalves; Venceslaine Prado Marques; Eduardo Velasco; Marilda M Siqueira
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

4.  Duration of viral shedding in hospitalized patients infected with pandemic H1N1.

Authors:  Silvia Meschi; Marina Selleri; Eleonora Lalle; Licia Bordi; Maria B Valli; Federica Ferraro; Giuseppe Ippolito; Nicola Petrosillo; Francesco N Lauria; Maria R Capobianchi
Journal:  BMC Infect Dis       Date:  2011-05-23       Impact factor: 3.090

5.  Secondary infection and clinical aspects after pandemic swine-origin influenza a (H1N1) admission in an Iranian critical care unite.

Authors:  Seyed Mohammadreza Hashemian; Payam Tabarsi; Seyed Alireza Nadji; Hamidreza Jamaati; Seyed Amir Mohajerani; Massoud Shamaee; Mandana Chitsazan; Golnar Radmand; Mohammadreza Maadani; Seyed Davoud Mansouri
Journal:  Int J Crit Illn Inj Sci       Date:  2014 Oct-Dec

6.  Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance.

Authors:  Rueshandra Roosenhoff; Erhard van der Vries; Anne van der Linden; Geert van Amerongen; Koert J Stittelaar; Saskia L Smits; Martin Schutten; Ron A M Fouchier
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

Review 7.  Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

8.  Shedding of the Pandemic Swine-Origin Influenza A Virus (H1N1) after Oseltamivir Administration.

Authors:  Leiyun Weng; Qiang Wang; Wei Wang; Peijun Ren; Vincent Deubel; Tetsuya Toyoda
Journal:  Influenza Res Treat       Date:  2010-12-14

9.  Infection with a Mouse-Adapted Strain of the 2009 Pandemic Virus Causes a Highly Severe Disease Associated with an Impaired T Cell Response.

Authors:  Isabelle Meunier; Olivier Morisseau; Émilie Garneau; Isabelle Marois; Alexandre Cloutier; Martin V Richter
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

Review 10.  Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age.

Authors:  James E Fielding; Heath A Kelly; Geoffry N Mercer; Kathryn Glass
Journal:  Influenza Other Respir Viruses       Date:  2013-12-02       Impact factor: 4.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.